COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that it has acquired an...